HomeACADEMIA
ACADEMIA

Lynparza Desirable for Use in Early-Stage Maintenance Therapy: Jikei Univ. Prof.
(Apr.2.2018)

Prof. Aikou Okamoto, Jikei University School of Medicine
Lynparza (olaparib) is desirable for use in early-stage maintenance therapy for ovarian cancer, said Aikou Okamoto, professor of the Department of Obstetrics and Gynecology at the Jikei University School of Medicine, at a press conference held by AstraZeneca on March 29 ...
(LOG IN FOR FULL STORY)

News Calendar